A Study of the Efficacy and Safety of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes
Status:
Completed
Trial end date:
2019-10-10
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of investigational doses of
once weekly dulaglutide when added to metformin in participants with type 2 diabetes with
inadequate blood sugar control.